Oxaliplatin

16 registered clinical trials studyying Oxaliplatin — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer NCT07366528	Ruijin Hospital	Phase 3
Completed	The Effect of Electrostimulation and Compression Applications on Neuropathy Symptoms and Quality of Life in th NCT07409987	Cumhuriyet University	N/A
Recruiting	NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC NCT06405490	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 2
Recruiting	XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC NCT05970302	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 2
Recruiting	Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage I NCT05920863	Zhejiang Cancer Hospital	Phase 2
Unknown	Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery NCT04962958	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 2
Not Yet Recruiting	Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III C NCT05841134	The First Affiliated Hospital of Zhengzhou University	Phase 2
Unknown	Electro-acupuncture for the Prevention and Treatment of Oxaliplatin-induced Neurotoxicity in Colorectal Cancer NCT05798884	Hong Kong Baptist University	N/A
Completed	A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemothera NCT06048146	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	N/A
Unknown	SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positiv NCT05218148	Aiping Zhou	Phase 2
Unknown	HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama NCT04627363	Sun Yat-sen University	Phase 2
Terminated	Impact of an Optimised Monitored Anesthesia on the Patients' Recovery After Cytoreduction Surgery Plus HIPEC NCT04104334	Ciusss de L'Est de l'Île de Montréal	N/A
Unknown	FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma NCT04393584	Blokhin's Russian Cancer Research Center	Phase 2 / Phase 3
Unknown	Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer NCT00961077	Soonchunhyang University Hospital	Phase 2
Completed	A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer NCT00504192	Soonchunhyang University Hospital	Phase 2
Completed	CCRT for Esophageal Cancer. NCT02607982	Hangzhou Cancer Hospital	Phase 2